|
|
|
Dr. SUBHAMOY DAS
|
|
|
|
|
|
Address 1
|
:
|
|
Address 2
|
:
|
|
Title
|
:
|
Dr.
|
First Name
|
:
|
SUBHAMOY
|
Last Name
|
:
|
DAS
|
University/Institution
|
:
|
Stanford University
|
Email ID
|
:
|
subhamoy.das@utexas.edu
|
City
|
:
|
Palo Alto
|
Country
|
:
|
United States
|
State
|
:
|
California
|
Zipcode
|
:
|
94305
|
|
|
|
|
Department
|
:
|
Neurosurgery
|
Company Name
|
:
|
|
Area of Research
|
Enteric Nervous System
|
Area of Expertise
|
Biomaterials, Tissue Engineering, Drug Delivery, Gene Editing, Cardiovascular thearpeutics
|
Brief Description of Research Interest :
|
Dr. Subhamoy Das received his M.S.E. and Ph.D. degrees in Biomedical Engineering from The University of Texas at Austin. He worked with Dr. Aaron B. Baker at UT Austin and developed a novel therapeutic to enhance growth factor activity for wound healing and revascularization. Prior to that, he finished undergraduate studies in Biotechnology and Biochemical Engineering from Indian Institute of Technology, Kharagpur. He joined UC Berkeley as a postdoc in June 2016 and worked on strategies for in vivo therapeutic delivery of CRISPR-Cas9 complex but didn't work out with the PI. So he recently moved on to another postdoc position at Stanford University where he will be investigating Enteric Nervous System. He has recently been elected as the Secretary/Treasurer of the Society for Biomaterials Cardiovascular Biomaterials Special Interest Group for 2017-2019.
|
Representative Publications :
|
*equal contribution
-
Maity S, Das S, Sadlowski CM, Vegesna GK, Murthy N. Thiophene bridged hydrocyanine – a new fluo-
rescent ROS probe. Chemical Communications, 2017. Submitted. (IF 6.567)
-
Maity S, Das S, Wang X, Adams-Sapper S, Riley L, Murthy N. A cephalosporin-dioxetane conjugate increases the detection sensitivity of beta-lactamase by four orders of magnitude. Organic Letters, 2017. Submitted. (IF 3.0)
-
Park B*, Sadlowski CM* , DasS ,Wetmore K, Arajo C, Deutschbauer A, Kerr L, Arkin A, Riley L, Murthy N. Nitro Sulfonyl Fluorides - a new family of pharmacophores for the development of antibiotics. Angewandte Chemie, 2017. Submitted. (IF 9.0)
-
Das S, Baker AB. Biomaterials and nanotherapeutics for enhancing skin wound healing. Frontiers in Bioengineering and Biotechnology, Oct 2016; 4:82. (no IF yet)
-
Das S, Majid M, Baker AB. Syndecan-4 enhances PDGF-BB activity in diabetic wound healing. Acta Biomaterialia, Sept 2016; 42:56-65. (IF 6.025)
-
Das S, Singh G, Majid M, Sherman MB, Mukhopadhyay S, Wright CS, Martin PE, Dunn AK, Baker AB. Syndesome therapeutics for enhancing diabetic wound healing. Advanced Healthcare Materials, Sept 2016; 5(17):2248-2260. (IF 5.797)
-
Monteforte AJ, Lam B, Das S, Mukhopadhyay S, Wright CS, Martin PE, Dunn AK, Baker AB. Glypican- 1 nanoliposomes for potentiating growth factor activity in therapeutic angiogenesis. Biomaterials, Jul 2016; 94:45-56. (IF 8.557)
-
Das S, Monteforte AJ, Singh G, Majid M, Dunn AK, Baker AB. Syndecan-4 enhances therapeutic angiogenesis after hindlimb ischemia in mice with type 2 diabetes. Advanced Healthcare Materials, May 2016; 5(9):1008-1013. (IF 5.797)
-
Tu C, Das S, Baker AB, Zoldan J, Suggs L. Nanoscale strategies - treatment for Peripheral Vascular Disease and Critical Limb Ischemia. ACS-Nano, Apr 2015; 9(4):3436-3452. (IF 12.881)
10. Das S, Singh G, Baker AB. Overcoming disease-induced growth factor resistance in therapeutic angiogenesis using recombinant co-receptors delivered by a liposomal system. Biomaterials, Jan 2014; 35(1):196-205. (IF 8.557)
|
Resume
|
:
|
Download
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|